Prof Dr. Aling Shen, Fujian University of Traditional Chinese Medicine, Fujian China, China
Dr. Aling Shen is an esteemed researcher in Integrative Chinese and Western Medicine, currently serving as Deputy Dean at the College of Integrated Chinese and Western Medicine, Fujian University of Traditional Chinese Medicine. With a strong foundation in both clinical and basic research, Dr. Shen’s work primarily focuses on the prevention and treatment of chronic diseases like hypertension and cancer. He has authored over 100 academic papers, many published in top-tier journals, and has been recognized with several prestigious awards for his contributions to the field.
profile 🌟📋
Scopus
Based on the resume of Aling Shen, it seems he has several strengths that make him a strong candidate for the “Best Researcher Award,” as well as some areas where there is room for improvement. Here’s a detailed analysis:
Strengths for the Award 💪🏆✨
Extensive Education and Training: Aling Shen has a robust academic background with a Bachelor’s, Master’s, and Doctorate in Integrated Chinese and Western Medicine from Fujian University of Traditional Chinese Medicine. His education is complemented by international exposure through his tenure at the University of Kansas Medical Center.
Diverse and High-Level Research Experience: Shen has been involved in a wide range of research projects, including principal investigator roles for National Natural Science Foundation projects and significant contributions to various high-impact projects. His role as a core member in obtaining clinical trial approval for a new Chinese medicine drug highlights his leadership in translating research into practical applications.
Significant Publications and Impact: With over 100 academic papers, including more than 80 SCI-indexed papers and publications in high-impact journals such as Cancer Research and Biomedicine & Pharmacotherapy, Shen has a strong publication record. His role as a first or corresponding author in several high-impact journals underscores his research prominence.
Innovative Contributions and Patents: Shen has applied for 10 national invention patents, with 8 granted, indicating a strong focus on innovation. This is further supported by his involvement in clinical trials for new drugs.
Recognition and Awards: He has received multiple provincial and ministerial-level awards, including the Fujian Provincial Science and Technology Progress Award and the Second National Excellent Doctoral Dissertation in Traditional Chinese Medicine. These accolades reflect his significant contributions to his field.
Professional Affiliations and Editorial Roles: His membership in several professional committees and his roles as a review editor and guest associate editor for prestigious journals show his active engagement in the academic community.
Areas for Improvement 🚀📈🔧
Broadening Research Impact Beyond Traditional Medicine: While Shen’s focus on integrated Chinese and Western medicine is a strength, exploring interdisciplinary research that integrates other fields could enhance the breadth and impact of his work. This could involve collaborating with researchers in fields such as biotechnology or public health.
Increasing Visibility in International Forums: Despite a strong publication record, increasing his presence at international conferences and symposia could enhance his visibility and networking opportunities. Presenting his research at such forums could foster greater international collaboration and recognition.
Expanding Research Focus: Although Shen has made significant contributions to the treatment of hypertension and cancer, diversifying his research focus to include emerging areas of medical research, such as precision medicine or regenerative medicine, could further establish him as a leader in his field.
Mentoring and Collaboration: Increasing his involvement in mentoring young researchers and fostering collaborative research teams could not only advance his own research goals but also contribute to the development of future researchers in his field.
Education 🎓
Bachelor’s Degree (2006-2011): Integrated Chinese and Western Clinical Medicine, Fujian University of Traditional Chinese Medicine.
Master’s Degree (2011-2014): Basic Research in Integrated Chinese and Western Medicine, Fujian University of Traditional Chinese Medicine.
Doctorate (2014-2017): Ph.D. in Basic Research in Integrated Chinese and Western Medicine, Fujian University of Traditional Chinese Medicine and University of Kansas Medical Center, USA.
Work Experience 💼
Aling Shen currently serves as the Deputy Dean of the College of Integrated Chinese and Western Medicine at Fujian University of Traditional Chinese Medicine. He also holds a leadership role at the Research Institute of Integrated Chinese and Western Medicine and has held key research and administrative positions in the institution. His research is focused on the integration of traditional Chinese medicine and modern clinical approaches to treat chronic diseases like hypertension and cancer.
Research Interests 🔬
Aling Shen’s primary research interests revolve around hypertension, cancer prevention, and integrated traditional Chinese and Western medicine. He combines pharmacology and clinical studies, focusing on drug development and innovative therapies. His work often explores novel approaches to combining traditional practices with cutting-edge medical research.
Awards 🏆
Fujian Provincial Natural Science Foundation Outstanding Youth Project recipient.
Youth Talent in the Second “Young Eagle Plan” of Fujian Province.
Selected for the National “Hundred, Thousand, and Ten Thousand Talent Project”.
Numerous awards for excellence in academic papers and mentorship in innovation and entrepreneurship.
Publications Top Notes 📚
Therapeutic potential of Pien Tze Huang in colitis-associated colorectal cancer: mechanistic insights from a mouse model
Baicalin ameliorates angiotensin II-induced cardiac hypertrophy and mitogen-activated protein kinase signaling pathway activation: A target-based network pharmacology approach
Pien Tze Huang Inhibits Proliferation of Colorectal Cancer Cells through Suppressing PNO1 Expression and Activating p53/p21 Signaling Pathway
Baicalin alleviates angiotensin II-induced cardiomyocyte apoptosis and autophagy and modulates the AMPK/mTOR pathway
Enhancing the therapeutic potential of isoliensinine for hypertension through PEG-PLGA nanoparticle delivery: A comprehensive in vivo and in vitro study
Efficacy and safety of Qingda granule versus valsartan capsule in Chinese grade 1 hypertensive patients with low-moderate risk: A randomized, double-blind, double dummy, non-inferiority, multi-center trial
Quercetin protects against hypertensive renal injury by attenuating apoptosis: an integrated approach using network pharmacology and RNA-Seq
Qing Hua Chang Yin ameliorates chronic colitis in mice by inhibiting PERK–ATF4–CHOP pathway of ER stress and the NF-κB signalling pathway
Effects of Liqi Tongbian decoction on gut microbiota, SCFAs production, and 5-HT pathway in STC rats with Qi Stagnation Pattern
Based on network pharmacology, gastrodin attenuates hypertension-induced vascular smooth muscle cell proliferation and PI3K/AKT pathway activation
Conclusion ✨🔍
Aling Shen is highly suitable for the “Best Researcher Award” due to his impressive track record in research, innovation, and publication. His extensive contributions to the integration of traditional and Western medicine, coupled with his significant accolades and leadership roles, highlight his exceptional achievements. Addressing areas for improvement, such as expanding research focus and increasing international engagement, could further enhance his profile and impact in the global research community.